-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
medsci.
medsci.
Recently, a research article was published in JAHA, an authoritative journal in the field of cardiovascular diseases.
Cardiovascular events
The researchers used the Chang Gung research database to design a cohort study and identified 7,114 patients diagnosed with rheumatoid arthritis.
Diagnosing coronary syndrome stroke
The average follow-up time of subjects was 4.
It can be seen that patients with rheumatoid arthritis with poor response to DMARD have a higher risk of developing acute coronary syndromes than those of controls whose disease can be controlled by DMARD .
Patients with rheumatoid arthritis who have a poor response to DMARD have a higher risk of developing acute coronary syndromes than those with rheumatoid arthritis who can control the disease by DMARD
Original source:
Original source:Chung‐Yuan Hsu.
Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome in this message
